Prognostic and Predictive Markers in Metastatic Renal Cell Carcinoma

被引：2
|
作者：
Khattak, Muhammad A. [1 ]
Bakr, Farrah [1 ]
Krzystanek, Marcin [2 ]
Szallasi, Zoltan [2 ,3 ]
Gerlinger, Marco [4 ]
Santos, Claudio [4 ]
Swanton, Charles [4 ]
Pickering, Lisa M. [1 ]
Gore, Martin E. [1 ]
Larkin, James M. G. [1 ]
机构：
[1] Royal Marsden Natl Hlth Serv Fdn Trust, London, England
[2] Tech Univ Denmark, DK-2800 Lyngby, Denmark
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Canc Res UK, London Res Inst, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 07期
基金：
英国医学研究理事会;
关键词：
ENDOTHELIAL GROWTH-FACTOR; HYPERTENSION; INHIBITOR; CANCER; EVEROLIMUS; SORAFENIB; SURVIVAL; CYTOKINE; RISK;
D O I：
10.1200/JCO.2012.46.9353
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：971 / 972
页数：3
相关论文
共 50 条
  • [41] Prognostic value of a systemic inflammatory response index in metastatic renal cell carcinoma and construction of a predictive model
    Gu, Liangyou
    Ma, Xin
    Wang, Lei
    Li, Hongzhao
    Chen, Luyao
    Li, Xintao
    Zhang, Yu
    Xie, Yongpeng
    Zhang, Xu
    ONCOTARGET, 2017, 8 (32) : 52094 - 52103
  • [42] Predictive and Prognostic Clinicopathologic Factors of Metastatic Renal Cell Carcinoma Treated with VEGF-Targeted Therapy
    Park, J. Y.
    Lee, J-L
    Ro, J. Y.
    Cho, Y. M.
    LABORATORY INVESTIGATION, 2013, 93 : 239A - 239A
  • [43] Predictive and Prognostic Clinicopathologic Factors of Metastatic Renal Cell Carcinoma Treated with VEGF-Targeted Therapy
    Park, J. Y.
    Lee, J-L
    Ro, J. Y.
    Cho, Y. M.
    MODERN PATHOLOGY, 2013, 26 : 239A - 239A
  • [44] Neopterin as a potential prognostic and predictive biomarker in metastatic renal cell carcinoma treated with immune checkpoint inhibitors
    Studentova, Hana
    Hola, Katerina
    Melichar, Bohuslav
    Spisarova, Martina
    EXPERT REVIEW OF ANTICANCER THERAPY, 2024, 24 (06) : 339 - 345
  • [45] Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma
    Petitprez, Florent
    Ayadi, Mira
    de Reynies, Aurelien
    Fridman, Wolf H.
    Sautes-Fridman, Catherine
    Job, Sylvie
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [46] GENETIC MUTATIONS AS PREDICTIVE BIOMARKERS IN METASTATIC RENAL CELL CARCINOMA
    Briggs, Logan
    Cone, Eugene B.
    Blute, Michael
    JOURNAL OF UROLOGY, 2021, 206 : E911 - E912
  • [47] Prognostic factors for survival of patients with metastatic renal cell carcinoma
    Ohlmann, C. -H.
    UROLOGE, 2009, 48 (06): : 625 - 626
  • [48] Prognostic factors and the role of nephrectomy in metastatic renal cell carcinoma
    Uygur, MC
    Usubütün, A
    Özen, H
    Ayhan, A
    Kendi, S
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1999, 18 (03): : 397 - 401
  • [49] GENETIC MUTATIONS AS PROGNOSTIC BIOMARKERS IN METASTATIC RENAL CELL CARCINOMA
    Briggs, Logan
    Blute, Michael
    Cone, Eugene B.
    JOURNAL OF UROLOGY, 2021, 206 : E1084 - E1085
  • [50] Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma
    Motzer, Robert J.
    Bukowski, Ronald M.
    Figlin, Robert A.
    Hutson, Thomas E.
    Michaelson, M. Dror
    Kim, Sindy T.
    Baum, Charles M.
    Kaftan, Michael W.
    CANCER, 2008, 113 (07) : 1552 - 1558
12345